| | | Single nucleotide variant (missense variant) | Familial cancer of breast +8 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +5 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | CHEK2-related cancer predisposition +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | CHEK2-related cancer predisposition +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +12 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | CHEK2-related cancer predisposition +9 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | CHEK2-related cancer predisposition +10 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | CHEK2-related disorder +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant tumor of prostate +5 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +6 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (missense variant) | Bone osteosarcoma +10 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | NICE approved PARP inhibitor treatment +21 more | |
| | | Single nucleotide variant (intron variant) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +8 more | |
| | | Single nucleotide variant (missense variant +1 more) | Malignant tumor of prostate +5 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +5 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +5 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (missense variant) | not specified +8 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Bone osteosarcoma +6 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +8 more | |
| | | Single nucleotide variant (intron variant) | Familial cancer of breast +7 more | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (splice acceptor variant) | Malignant tumor of prostate +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +7 more | GConflicting classifications of pathogenicity |
| | | Microsatellite (inframe_deletion) | Familial cancer of breast +5 more | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome 2 +7 more | |
| | | Single nucleotide variant (missense variant) | not specified +6 more | |
| | | Single nucleotide variant (missense variant) | not specified +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +5 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary cancer-predisposing syndrome +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice acceptor variant +1 more) | Familial cancer of breast +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +2 more) | not provided +6 more | |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Familial cancer of breast +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant) | Inherited breast cancer and ovarian cancer +12 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +8 more | |
| | | Single nucleotide variant (nonsense +1 more) | Familial cancer of breast +7 more | |
| | | Single nucleotide variant (nonsense +1 more) | CHEK2-related cancer predisposition +8 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | CHEK2-related cancer predisposition +14 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (splice donor variant) | RECLASSIFIED - CDH1 POLYMORPHISM +8 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +8 more | |
| | | Single nucleotide variant (nonsense +1 more) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +7 more | |